RAMP CK-MB Assay - Taiwan Registration 5ec4b2ac2e400545d356b9ccf8070de6
Access comprehensive regulatory information for RAMP CK-MB Assay in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 5ec4b2ac2e400545d356b9ccf8070de6 and manufactured by RESPONSE BIOMEDICAL CORPORATION. The authorized representative in Taiwan is RECHI CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Registration Details
5ec4b2ac2e400545d356b9ccf8070de6
Ministry of Health Medical Device Import No. 027925
DHA05602792500
Product Details
This product is a quantitative immunochromolayer analysis method, which is an in vitro diagnostic product for detecting CK-MB concentration in EDTA whole blood, and needs to be used with RAMP Reader System or RAMP 200 System.
A Clinical chemistry and clinical toxicology
A1215 Creatine phosphocatalyzed?/creatine excitation or isomeric test system
Imported from abroad
Dates and Status
Dec 02, 2015
Dec 02, 2025

